EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuron‐Targeted Exosomal Delivery of siRNA Against RIPK3 Slows Neurodegenerative Progression in Alzheimer's Disease

Chi Zhang iD, Jiaqi Zhang, Yuzhi Wang, Yaodong Wang, Peng Lin, Yanling Wang, Zixuan Tang iD, Jintai Yu, Qin Zhou, Feiyun Cui iD

Advanced Science · 2026

DOI: 10.1002/advs.76558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Chi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Exosomes, Alzheimer Disease, RNA, Small Interfering, Receptor-Interacting Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major challenge in RNA therapeutics for central nervous system disorders is the lack of delivery systems capable of crossing the blood–brain barrier (BBB) while achieving cell‐type‐specific targeting. Herein, we develop an engineered exosomal siRNA delivery platform for systemic, neuron‐targeted RNA transport to the brain. The platform leverages exosomes derived from an immortalized mouse hippocampal neuronal cell line as a biomimetic and functionally privileged material source, enhancing neuronal uptake and intracellular delivery efficiency. Through surface functionalization with a rabies virus glycoprotein‐derived peptide, the system enables receptor‐mediated BBB transcytosis and programmable siRNA loading. In human cortical organoids, the platform achieves efficient cytosolic delivery and robust gene silencing in neurons, demonstrating high delivery precision and bioavailability. As a proof of concept, targeting receptor‐interacting protein kinase 3 (RIPK3) modulates necroptosis, a key pathway in inflammatory neurodegeneration. In transgenic mouse models, systemic administration suppresses RIPK3/MLKL signaling, reduces neuronal loss, and alleviates neuroinflammation and tau‐associated pathology. Transcriptomic analyses further indicate stabilization of neuronal homeostasis across vulnerable brain regions. Collectively, the study establishes a modular and programmable exosomal RNA delivery platform and highlights age‐defined, cell‐derived biomaterials as a generalizable strategy for overcoming delivery barriers in neurological diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesAlzheimer DiseaseRNA, Small InterferingReceptor-Interacting Protein Serine-Threonine KinasesNeuronsAnimalsMiceHumansBlood-Brain BarrierDisease Models, AnimalMice, Transgenic

Stichwörter der Autor:innen

RNA interferenceblood–brain barrier (BBB)drug deliverynecroptosisneuroprotectionsynaptic plasticity

Substanzen

RNA, Small InterferingReceptor-Interacting Protein Serine-Threonine KinasesRipk3 protein, mouse

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, China.
  • The Heilongjiang Provincial Joint Laboratory of Basic Medicine and Multiple Organ System Diseases (International Cooperation), Harbin, Heilongjiang, China.
  • Heilongjiang Provincial Key Laboratory of Human Microphysiological Systems and Organoids-on-a-Chip (Harbin Medical University), Harbin, Heilongjiang, China.
  • Department of Neurology and National Center For Neurological Disorders, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center For Brain Science, Shanghai Medical College, Fudan Universi…

ORCID-Profile: Chi Zhang, Zixuan Tang, Feiyun Cui

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Heilongjiang Province
  • "Spring Goose" Talent Team Support Program of Heilongjiang Province
  • Funding Program for Preferential Returned Scholars of Heilongjiang Province
  • Young Elite Scientist Sponsorship Program of Heilongjiang Province

Zitieren

APA

Zhang, C., Zhang, J., Wang, Y., Wang, Y., Lin, P., Wang, Y., Tang, Z., Yu, J., Zhou, Q., & Cui, F. (2026). Neuron‐Targeted Exosomal Delivery of siRNA Against RIPK3 Slows Neurodegenerative Progression in Alzheimer's Disease. Advanced Science. https://doi.org/10.1002/advs.76558

Vancouver

Zhang C, Zhang J, Wang Y, Wang Y, Lin P, Wang Y, et al. Neuron‐Targeted Exosomal Delivery of siRNA Against RIPK3 Slows Neurodegenerative Progression in Alzheimer's Disease. Advanced Science. 2026. doi:10.1002/advs.76558

BibTeX
@article{Zhang2026,
  author = {Zhang, Chi and Zhang, Jiaqi and Wang, Yuzhi and Wang, Yaodong and Lin, Peng and Wang, Yanling and Tang, Zixuan and Yu, Jintai and Zhou, Qin and Cui, Feiyun},
  title = {Neuron‐Targeted Exosomal Delivery of siRNA Against RIPK3 Slows Neurodegenerative Progression in Alzheimer's Disease},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76558}
}
Kostenlos starten →